Ceribell builds a point-of-care EEG system for acute care that enables rapid seizure detection and continuous monitoring using portable hardware and AI algorithms. The FDA 510(k)-cleared Ceribell System is deployed in ICUs and emergency departments at hospitals across the U.S., including community and academic centers. Founded in 2014 and headquartered in Sunnyvale, California, the company sells its neurodiagnostic hardware, software, and disposables to hospital providers.